Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Genitourinary 2Other hematologic neoplasm 1Myeloid 1Lymphoid 1Endocrine 1Dermatologic 1

Conditions

Prostatic Neoplasms 1Cystectomy 1

Interventions

Docetaxel 390pembrolizumab 326Prednisone 285Gemcitabine 273enzalutamide 256Radiotherapy 251Nivolumab 248Magnetic Resonance Spectroscopy 247Cisplatin 209Abiraterone Acetate 198Radiosurgery 184Leuprolide 182Sunitinib 169Carboplatin 161bicalutamide 148Goserelin 145Androgen Antagonists 142Specimen Handling 138Ipilimumab 128Paclitaxel 125Cyclophosphamide 116acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 110Bevacizumab 109Everolimus 107apalutamide 99abiraterone 99cabozantinib 98atezolizumab 97Sorafenib 97Radiation 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Trimethoprim × Genitourinary × Clear all
NCT06536374 2025-11-12

Folate Study in Men With Advanced Prostate Cancer

University of California, San Diego

Phase 2 Not yet recruiting
50 enrolled
Genitourinary

Prostatic Neoplasms

NCT06709196 2025-01-09

REINFORCE

Rigshospitalet, Denmark

Phase 4 Recruiting
248 enrolled
Genitourinary

Cystectomy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡